Proteomics International Laboratories Ltd. (AU:PIQ) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Proteomics International Laboratories Ltd has announced promising results for its PromarkerEndo blood test, which could revolutionize the diagnosis of endometriosis, a condition affecting millions of women. Published in ‘Human Reproduction,’ the study showcases the test’s high accuracy in identifying all stages of the disease, offering a non-invasive alternative to current diagnostic methods. With potential applications in fertility treatments, the test is poised to significantly impact women’s healthcare and is targeted for launch in Australia by Q2 2025.
For further insights into AU:PIQ stock, check out TipRanks’ Stock Analysis page.